Skip to content
PICO Portalanswers from OpenAlex

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients

PaperCitations, authors & open-access status

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients is a paper indexed in PICO Portal from OpenAlex.

How many citations does Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients have?

PICO Portalcitation count

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients has 571 citations in the OpenAlex counts PICO Portal stores.

When was Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients published?

PICO Portalyear

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients has 2011 year in the PICO Portal index.

What is the open-access status of Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients?

PICO Portaloa status

Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients has closed oa status in the PICO Portal index.

What is the DOI of Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients?

PICO Portaldoi

The DOI for Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients is on the source record.

What is the PMID of Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients?

PICO Portalpmid

The PMID for Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients is on the source record.

What is the OpenAlex record for Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients?

PICO Portalopenalex

The OpenAlex for Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial